Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Avalo Therapeutics, Inc. | 2,592,743 | reported | 04 Dec 2017 | tx 1+285 |
| NASTECH PHARMACEUTICAL CO INC | 300,000 | reported | 12 Jul 2018 | tx 3+1,800,040 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jul 2018 | PURCHASE | NASTECH PHARMACEUTICAL CO INC | 300,000 | 0.00 USD | deriv |
| 12 Jul 2018 | PURCHASE | NASTECH PHARMACEUTICAL CO INC | 40 | 5000.00 USD | deriv |
| 10 Jul 2018 | GRANT_AWARD | NASTECH PHARMACEUTICAL CO INC | 1,500,000 | 0.00 USD | deriv |
| 04 Dec 2017 | PURCHASE | Avalo Therapeutics, Inc. | 285 | 1.77 USD |